Advertisement

Solvents

  • Curtis L. BaysingerEmail author
Chapter

Abstract

Solvents are a diverse group of compounds absorbed through the lungs by inhalation and are infrequently abused by pregnant women. Chronic use leads to multi-organ system damage, and electrolyte abnormalities may occur more frequently than with the abuse of other drugs. Obstetric and neonatal outcomes are likely poorer, but peripartum obstetric and anesthetic management of the non-intoxicated patient is similar to that of the non-solvent abusing mother. General anesthesia may be required in the acutely intoxicated patient who is uncooperative; responses to drugs commonly used during general anesthesia may be altered in unpredictable ways.

Keywords

Addiction Obstetric anesthesia Congenital anomalies Toluene Solvents 

References

  1. 1.
    Tenebein M. Clinical/biophysiologic aspects of inhalant abuse. In: Sharp CW, Beauvais F, Spence R, editors. Inhalant abuse: a volatile agenda. National Institute of Drug Abuse Research Monograph 129. Rockville: National Institute on Drug Abuse; 1992. p. 173–80.Google Scholar
  2. 2.
    Reynolds EW, Bada HS. Pharmacology of drugs of abuse. Obstet Gynecol Clin N Am. 2003;30:501–22.CrossRefGoogle Scholar
  3. 3.
    Press A, Drone AK. Solvent sniffing: physiologic effects and community control measures. Pediatrics. 1967;39:451–61.PubMedGoogle Scholar
  4. 4.
    Williams JF, Storck M. Inhalant abuse. Pediatrics. 2007;119:1009–17.CrossRefGoogle Scholar
  5. 5.
    Substance Abuse and Mental Health Services Administration. Results from the 2013 National Survey on Drug Use and Health: summary of national findings. NSDUH Series H-48, HHS Publication No. (SMA) 14-4863. Rockville: Substance Abuse and Mental Health Services Administration; 2014.Google Scholar
  6. 6.
    Sullivan JT. Substance abuse and the drug addicted mother. In: Suresh MS, Segal S, Preston RL, Fernando R, Mason CL, editors. Shnider and Levinson’s anesthesia for obstetrics. 5th ed. Baltimore: Wolters Kluwer/Lippincott Williams and Wilkins; 2013. p. 683–98.Google Scholar
  7. 7.
    Jones HE, Balster RL. Inhalant abuse in pregnancy. Obstet Gynecol Clin N Am. 1998;25:153–67.CrossRefGoogle Scholar
  8. 8.
    Hersh JH, Podruch PE, Rogers G, Weiskopf B. Toluene embryopathy. J Pediatr. 1985;106:922–7.CrossRefGoogle Scholar
  9. 9.
    Kuczkowski KM. Anesthetic implications of drug abuse in pregnancy. J Clin Anesth. 2003;15:382–94.CrossRefGoogle Scholar
  10. 10.
    Tenebein M, Casiro OG, Seshia MM, Debooy VD. Neonatal withdrawal from maternal volatile substance abuse. Arch Dis Child Fetal Neonatal Ed. 1996;74:F204–7.CrossRefGoogle Scholar
  11. 11.
    Reyes de la Rocha S, Brown MA, Fortenberry JD. Solvent abuse: pulmonary function complications and perinatal outcomes. Obstet Gyencol. 1991;77:504–9.Google Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of AnesthesiologyVanderbilt University Medical Center, Vanderbilt University HospitalNashvilleUSA

Personalised recommendations